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Objective: The patellofemoral joint (PFJ) is important in early detection of knee osteoarthritis (OA). Little
is known about the relationship between speciﬁc clinical ﬁndings and PFJ Magnetic resonance Imaging
(MRI) features. The objective was to examine the relationship between (early) clinical ﬁndings and PFJ
MRI features in females (45e60 years) without knee OA (PFJ or tibiofemoral joint (TFJ) OA) based on a
recently suggested MRI deﬁnition.
Methods: MRIs of knees of women of a sub-study of the Rotterdam Study were scored with semi-
quantitative scoring. Speciﬁc patellar tests were performed on physical examination. Current knee
pain and history of patellar knee pain were reported. Binomial logistic generalized estimated equations
were used to determine the association between clinical ﬁndings of OA and PFJ MRI features. All asso-
ciations were adjusted for age, body mass index (BMI) and TFJ MRI features.
Results: In 888 women (1776 knees, mean age: 55.1 years and mean BMI: 27.0 kg/m2) we found sig-
niﬁcant associations between crepitus and all PFJ MRI features (Odds ratios (OR) range: 2.61e5.49). A
history of patellar pain was signiﬁcantly associated with almost all PFJ MRI features (ORcartilage: 1.95;
ORcysts: 1.86; ORbone marrow lesions: 1.83), except for osteophytes. No signiﬁcant associations were found
between the clinical ﬁndings and TFJ MRI features.
Conclusion: Crepitus and history of patellar pain are clinical ﬁndings that indicate PFJ lesions seen on
MRI. These tests could help to indicate signs of PFJOA. Follow-up data needs to conﬁrm whether these
tests have an additional diagnostic value for early knee OA in PFJ or TFJ.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Traditionally, research on knee OA has been primarily focused
on the tibiofemoral joint (TFJ), however the awareness of the
importance of the patellofemoral joint (PFJ) has increased in recent: D. Schiphof, Erasmus MC,
ox 2040, 3000 CA Rotterdam,
4-47-66.
hiphof), m.vanmiddelkoop@
gmail.com (B.M. de Klerk),
mc.nl (A. Hofman), b.koes@
nl (H. Weinans), s.bierma-
ternational. Published by Elsevier Lyears1e5. In a recent review the PFJ is described as is an important
source of symptoms, maybe more important than the TFJ
compartment6. An early recognition of PFJOA might be important
to reduce or intervene at the symptoms which occur with knee OA.
Different risk factors were found for PFJOA in comparison with
TFJOA, which conﬁrms the aberrant role of the PFJ in OA7. Associ-
ations were found between increased severity of radiographic
isolated PFJOA and higher levels of pain, stiffness and functional
limitations3. It has even been suggested that OA begins in the PFJ8.
OA, usually diagnosed at an advanced stage, cannot be prevented or
cured yet. Interventions in an earlier stage may be more prom-
ising9, but ﬁrst the early stage has to be identiﬁed. The identiﬁca-
tion of PFJOA seems to play an important role in early8 and maybe
even preclinical stage of knee OA.td. All rights reserved.
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ten key recommendation for diagnosis of knee OA in general
practice10. The recommendations are based on the whole knee, but
there might be clinical ﬁndings that are speciﬁc for PFJOA or TFJOA.
Previous studies have explored the ability of clinical ﬁndings to
distinguish PFJOA and TFJOA4,11. In a cross-sectional study among
OA patients, an association between knee pain and osteophytes
scored onMagnetic resonance Imaging (MRI) was found only when
an osteophyte was located in the patellofemoral compartment or
when more than four osteophytes were present anywhere in the
knee12. Several distinctive clinical ﬁndings were found for moder-
ate to severe isolated radiographic PFJOA, but there were barely
distinctive clinical ﬁndings for mild isolated radiographic PFJOA4.
Still, little is known about the relationship between speciﬁc phys-
ical examination ﬁndings of the PFJ and MRI features of PFJOA. MRI
allows another perspective of structural abnormalities associated
with PFJOA. Bone marrow oedema, osteophytes, and cartilage le-
sions are MRI features that may be associated with speciﬁc clinical
ﬁndings from clinical history and physical examination. These as-
sociations may occur even at an early stage and help us to identify
PFJOA.
Therefore, the present study aims to examine the relationship
between clinical ﬁndings of the PFJ and prevalent PFJ MRI features
in a population-based middle-aged female cohort.
Patients and methods
Population
The study population is a subpopulation (RS-III-1) of the Rot-
terdam Study, a population-based cohort study in which the inci-
dence and risk factors for chronic disabling diseases are
investigated. All participants of the RS-III-1 cohort were 45 years
and live in Rotterdam; the participants were included between
2006 and 200813,14. The Medical Ethics committee of the Erasmus
Medical Centre approved the study and all participants provided
written consent. All participants were interviewed at home for
demographic data, and were invited to visit the research centre for
a physical examination and radiographs of the knees. Height and
weight were measured at the research centre. Of these participants
of the Rotterdam Study (RS-III-1) we invited 1116women, aged 45e
60 years, to join a sub-study for investigation of early signs of knee
OA. 891 women that participated in this sub-study underwent MRI
and physical examination of both knees and ﬁlled in a question-
naire. All women were screened for contra-indications for MRI.
Clinical data
Height, weight, body mass index (BMI) and age were deter-
mined. Current knee pain was deﬁned if participants experienced
pain in the knee at baseline (no/yes, left and/or right). Presence of
history of patellar pain was deﬁned as having had pain of the pa-
tella in history i.e., sometimes in combination with locking and
grinding, especially during walking stairs, headwind cycling,
squatting and sitting (no/yes, left and/or right). Two trained re-
searchers both examined approximately half of the participants.
The physical exam included assessment of pain at palpation at the
medial and lateral patellar edges, the quadriceps tendon and
patellar ligament, and the tibial tuberosity. Furthermore, we tested
whether the participants reported pain with the patellar
compression test15, and if there was crepitus in the knee during
active ﬂexion or extension of the knee. Crepitus was deﬁned as a
hearable grinding noise and/or palpable vibrations in the knee,
detected by the hand of the investigator rested on the patella of the
participant.MRI acquisition
We performed a multi-sequence MRI protocol on a 1.5-T MRI
scanner (Signa Excite 2, General Electric Healthcare, Milwaukee,
Wisconsin). All participants were scanned with an eight-channel
cardiac coil, so that two knees could be scanned at once without
repositioning the subject.
The protocol consisted of a sagittal dual echo fast spin echo (FSE)
proton density (TR 4900 ms; TE 11 ms) and T2 (TR 4900 ms; TE
90 ms) weighted sequence (slice thickness 3.2 mm, ﬁeld of view
15 cm2), a sagittal FSE T2 weighted sequence with fat suppression
(TR/TE 6800/80, slice thickness 3.2 mm, ﬁeld of view 15 cm2), a
sagittal spoiled gradient echo sequence with fat suppression (TR/TE
20.9/2.3, ﬂip angle 35, slice thickness 3.2 (1.6)mm, ﬁeld of view
15 cm2) and a fast imaging employing steady state acquisition
(FIESTA) sequence (TR/TE 5.7/1.7, ﬂip angle 35, slice thickness
1.6 mm, ﬁeld of view 15 cm2). This FIESTA sequence was acquired in
the sagittal plane, and reformatted in coronal and axial plane. Total
scanning time was 27 min for two knees.
MRI interpretation
An extensively trained researcher, who was blinded for any
clinical or radiographic data, scored all MRIs of the knees with the
semi-quantitative comprehensive scoring system described in
detail elsewhere16. The researcher, a human movement scientist
with extensive training in anatomy, is trained by a highly experi-
enced musculoskeletal radiologist with 35 years of experience. In
addition she had a training at the institute where the used semi-
quantitative scoring system, the Knee Osteoarthritis Scoring Sys-
tem (KOSS), is developed. An experienced musculoskeletal radiol-
ogist (5 years of experience), also blinded for any clinical and
radiographic data, scored a random sample of 30 knees to deter-
mine the inter-observer reliability. Cartilage lesions, osteophytes,
bone marrow lesions (BML), and subchondral cysts were scored at
the following nine locations: crista patellae, medial and lateral
patellar facet, medial and lateral trochlear facet (anterior femur),
the medial and lateral femoral condyle, and the medial and lateral
tibia plateau.
Cartilage lesions were graded as diffuse or focal. The sagittal FSE
proton density and the FIESTA scan in all three planes were used to
assess the TFJ and PFJ. The surface extent of a lesion was classiﬁed
by its maximal diameter and was graded as: grade 0, absent; grade
1, minimal (<5mm); grade 2, moderate (5e10mm); grade 3, severe
(>10 mm). Lesion depth was graded as: grade 0, absent; grade 1,
<50% reduction of the cartilage thickness; grade 2, >50% reduction
of cartilage thickness; grade 3, full thickness or nearly full thickness
cartilage defect.
Osteophytes were assessed in all three planes, using the
following scale: grade 0, absent; grade 1, minimal (<3 mm); grade
2, moderate (3e5mm); grade 3 severe (>5mm). Subchondral cysts
were graded as follows: grade 0, absent; grade 1, minimal (<3mm);
grade 2, moderate (3e5 mm); grade 3, severe (>5 mm). BMLs were
scored on the T2 weighted sequence with fat suppression and
graded as follow: grade 0, absent; grade 1, minimal (<5mm); grade
2, moderate (5 mme2 cm); grade 3; severe (>2 cm). A BML was
deﬁned as an ill-deﬁned area of increased intensity.
Degenerativemeniscal lesions were scored at the proton density
sequence, as follows: grade 0, absent; grade 1, when a small central
focus of intermediate signal intensity on the proton density
sequence was noticed in the meniscus; grade 2, when the intra-
meniscal focus of intermediate signal intensity was surrounded by
a broad, hypointense peripheral rim; grade 3, when only a thin,
hypointense peripheral rim outlined the intermediate signal in-
tensity meniscal center. A horizontal meniscal tear (0-1) was
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with a superior or inferior margin.
The inter-observer reliability was calculated with the kappa as
well as the prevalence adjusted bias adjusted kappa (PABAK). The
PABAK allows for the prevalence of a ﬁnding and the bias of the
observers for that ﬁnding and provides therefore a more realistic
estimate for agreement than the kappa, if the prevalence of the
features is low. The PABAK is calculated as 2po  1, where po is the
observed proportion of agreement17. For the interpretation of
PABAK we used the same cut-offs as used for kappa18. The inter-
observer reliability was moderate to nearly perfect with the
PABAK (Table I). For meniscal degeneration the PABAK was 0.47
(k ¼ 0.47) and for meniscal horizontal tear the PABAK was 0.87
(k ¼ 0.0).
For the present analysis of the separate lesions, we dichoto-
mized all scores (absent ¼ 0, present ¼ 1 (score of 1)).
MRI OA deﬁnition
To identify the participants with present OA in the PFJ or TFJ a
recently proposed MRI deﬁnition for knee OA by Hunter et al. was
used19. Patellofemoral OA (PFOAMRI) was deﬁned as a deﬁnite
osteophyte and partial or full thickness cartilage loss in the patella
or the trochlea (anterior femur). TheMRI deﬁnition for tibiofemoral
OA (TFOAMRI) was deﬁned as the presence of a deﬁnite osteophyte
and full thickness cartilage loss, or one of these features and two of
the following features: (1) subchondral BML or cyst not associated
with meniscal or ligamentous attachments, (2) meniscal subluxa-
tion, maceration or degeneration (including a horizontal tear), (3)
partial thickness cartilage loss, or (4) bone attrition.
To enable use of these deﬁnitions, the scores of the features
were dichotomised, although differently than for the separate le-
sions. Grade 1 and 2 cartilage lesions were classiﬁed as partial
thickness lesions and grade 3 cartilage lesions were classiﬁed as full
thickness lesions. Grade 2 or 3 osteophytes were classiﬁed as def-
inite osteophyte. BML and cysts were present when scored as grade
1 or higher. To score ‘present’ on the second feature: ‘meniscal
subluxation, maceration or degeneration (including a horizontal
tear)’ meniscal degeneration had to be assessed with a grade 1 or
more or there had to be a horizontal tear. We did not scoremeniscal
subluxation. Bone attrition was disregarded in the deﬁnition,
because we did not assess bone attrition. A knee still needed two of
the three remaining features to be deﬁned as having TFOAMRI.
Knee OA was deﬁned as having TFOAMRI and/or PFOAMRI. Not
having knee OA was therefore deﬁned as not having OA in neither
PFJ nor TFJ. Knees that did not fulﬁl the criteria for knee OA
(TFOAMRI and/or PFOAMRI) could still have MRI OA features (carti-
lage lesions, osteophytes, cysts, BMLs) commonly seen in OA. These
knees were deﬁned as not having OA, but were considered as
having early OA.Table I
Inter-observer reliability of MRI-lesions
Femur
PABAK (95%CI)
[kappa(95%CI)]
Tibia
PABAK (95%CI)
[kappa(95%CI)]
Patella
PABAK (95%CI)
[kappa(95%CI)]
Cartilage
lesions
0.48 (0.24e0.72)
[0.29(0.05e0.53)]
0.93 (0.26e1.0)
[0.66(0.02 to 1.0)]
0.87 (0.64e1.0)
[0.84 (0.6e1)]
Osteophytes 0.73 (0.21e1.0)
[0.26(0.26 to 0.78)]
0.93 (0.3e1.0)
[0.65(0.02e1.0)]
0.60 (0.50e0.70)
[0.1(0.2 to 0.0)]
BMLs/cysts 0.47 (0.15e0.78)
[0.44(0.12e0.75)]
0.93 (0.63e1.0)
[0.84(0.53e1.0)]
0.60 (0.25e0.95)
[0.49(0.14e0.84)]
PABAK: Prevalence adjusted bias adjusted kappa; 95%CI: 95% conﬁdence interval of
kappa.Statistical analysis
Descriptive statistics (means, standard deviations (SD)) were
applied to describe the participants’ characteristics. If a physical
exam outcome or feature was found in 1% or less it was not
analysed.
For the association between the various PFJ MRI features and
clinical ﬁndings (including current knee pain and history of patellar
pain) we used a binomial logistic Generalized Estimating Equations
(GEE) regression model, which takes into account the correlations
between the right and left knee within a person. We adjusted all
associations for age, BMI, and the presence of TFJ MRI features
(cartilage lesions, osteophytes, cysts and BMLs). The odds ratio (OR)
represents the odds that the clinical ﬁnding will be present in the
knees with the PFJ MRI feature compared to the odds that the
clinical ﬁnding will be present in the knees without the PFJ MRI
feature, regardless of age, BMI and presence of TFJ MRI features. We
performed the same analyses for associations between TFJ MRI
features and the clinical ﬁndings (adjusted for age, BMI, and PFJ
MRI-lesions) to show the difference between PFJ and TFJ. The ORs
were reported with corresponding 95% conﬁdence intervals (CI).
Analyses were performed in knees without knee OA (deﬁned as
TFOAMRI and/or PFOAMRI) to ﬁnd out if the clinical ﬁndings are
indicative for OA at an early stage. The current population is a
population at risk for OA, women aged 45e60 years. In supple-
mentary data online analyses of all participants (with and without
knee OA) were shown. Therewere participants with OA in one knee
and no OA in the other knee. The analyses were performed on the
knee-level; therefore it was possible that there was only one knee
of a participant in the analyses without knee OA. Also in supple-
mentary data were shown the associations of the independent MRI
features with clinical ﬁndings in participants without knee OA
additionally adjusted for the other PFJ MRI features.
Furthermore the pre- and post-test probabilities of the clinical
ﬁndings that showed a signiﬁcant association with an MRI feature
were calculated to show the probability of having any MRI lesion
when testing positive on a clinical test. Since we performed mul-
tiple testing, we consider the results with a P-value less than .001
statistically signiﬁcant. All analyses were performed with PASW
Statistics 20 (SPSS Inc, Chicago, USA).
Results
Of 1116 invited women, 891 womenwere included (1782 knees)
and underwent MRI of the knees. Most important reasons for non-
participation were: no time/no interest (51.1%) and fear of MRI
(24.4%). Other reasons (24.5%) were sickness, moving out of the
region or country, language problems and unattainable. Fig.1 shows
the ﬂowchart of the inclusion of the study population. Of the 891
included, threewomenwere excluded for the present study because
of missing data on age and/or BMI. Characteristics of the remaining
888 women are shown in Table II, as well as the physical exam
outcomes and prevalence of MRI-OA-features of their knees. Mean
age was 55.1 year (SD: 3.7), mean BMI was 27.0 kg/m2 (SD: 4.8).
MRI OA deﬁnition
Of 888 women 180 women (20.3% of all women) had TFOAMRI
and/or PFOAMRI in one or both knees. Fifty-ﬁvewomen had isolated
PFOAMRI (6.2% of all women), 73 women had isolated TFOAMRI (8.2%
of all women) and 52 women had PFOAMRI and TFOAMRI in one or
both knees (5.9% of all women). The numbers are different when
analysed per knee: 242 knees (13.6%) were deﬁned as having knee
OA of the 1776 knees. Eighty-one knees (4.6%) were deﬁned as
having isolated PFOAMRI, 105 knees (5.9%) were deﬁned as having
Fig. 1. Flowchart of the inclusion of the study population.
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PFOAMRI and TFOAMRI [Fig. 1].
MRI features
Of those who did not fulﬁl the criteria for PFOAMRI or TFOAMRI
(824 women and 1518 knees) 15% (235 knees) still had cartilage
defects, 25% (384 knees) had osteophytes in the PFJ; and 10% (162
knees) had cartilage defects and 24% (347 knee) osteophytes in the
TFJ (Table II). Pain at the tibial tuberosity was found in only 1% of the
knees and we therefore removed this feature from further analyses.
Tables III and IV show the ORs (95%CI) of the associations between
the physical exam outcomes and theMRI features of the PFJ and TFJ,
respectively, in the knees without knee OAMRI.Associations in participants without knee OAMRI
Clinical ﬁndings and MRI features in the PFJ (Table III)
The presence of crepitus was signiﬁcantly associated with all PFJ
MRI features (ORcartilage lesions¼ 5.49 (3.79e7.94); ORosteophytes¼ 2.61
(2.00e3.40); ORcysts ¼ 2.82 (2.00e3.98); ORBML¼ 3.70 (2.71e5.04)).
History of patellar pain was signiﬁcantly associated with carti-
lage lesions, cysts and BMLs of the PFJ (ORcartilage lesions ¼ 1.95
(1.39e2.72); ORcysts¼ 1.86 (1.32e2.61); ORBMLs ¼ 1.83 (1.33e2.50)).
Current knee painwas only associatedwith BMLs (OR¼ 2.09 (1.38e
3.15)). No signiﬁcant associations were found between PFJ MRI
features and pain at the patellar edge, pain at the quadriceps
tendon, pain at the patellar ligament, and with a positive patellar
compression test.
Table II
Demographics of study population
All
Nparticipants ¼ 888
Nknees ¼ knees
Without any OA in one or both knees (based on the MRI deﬁnition)*
Nparticipants ¼ 824
Nknees ¼ 1518
Participants N Mean SD N Mean SD
Age 888 55.1 3.7 824y 54.9 3.7
BMI 888 27.0 4.8 824 26.8 4.5
Knees N assessed N having feature % knees having feature N assessed N having feature % knees having feature
Left/right 1776 888/888 50/50 1518 772/746 50.9/49.1
History of patellar pain 1772 505 28.5 1515 371 24.5
Current knee pain 1774 248 14.0 1516 173 11.4
Physical exam
Pain at the patellar edges 1769 48 2.7 1513 29 1.9
Pain at the quadriceps tendon 1771 24 1.4 1517 19 1.3
Pain at the patellar ligament 1772 60 3.4 1518 46 3.0
Pain at the tibial tuberosity 1768 17 1.0 1514 12 0.8
Compression test pain 1762 350 19.9 1510 274 18.1
Crepitus 1744 771 44.2 1493 608 40.7
PFJ MRI features
Cartilage defect 1759 403 22.9 1516 235 15.5
Osteophytes 1764 596 33.8 1517 384 25.3
Cysts 1765 269 15.2 1513 194 12.8
BMLs 1765 397 22.5 1513 285 18.8
PF OA 1760 137 7.8 1518 e e
TFJ MRI features
Cartilage defect 1763 301 17.1 1517 162 10.7
Osteophytes 1766 593 33.6 1517 374 24.7
Cysts 1765 216 12.2 1513 142 9.4
BMLs 1765 364 20.6 1513 236 15.6
TF OA 1768 161 9.1 1518 e e
SD, standard deviation.
* The MRI deﬁnition for knee OA (PFOAMRI and/or TFOAMRI) is described in the method section.
y 64 participants are in these analysis with only one knee, without OA.
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No signiﬁcant associations were found between any clinical
ﬁnding and TFJ MRI features.
There were no knees that had both cysts and pain at the patellar
edge. Therefore no OR could be calculated for this association.
Pre- and post-test probabilities of crepitus, history of patellar pain
and the combination on MRI-OA-features
Table V shows the pre- and post-test probabilities of having any
lesion on the PFJ or the TFJ in the participantswithout kneeOAMRI.We
tested crepitus and history of patellar pain and the combination of
these two (having both presence of crepitus and a history of patellar
pain). In general, all post-test probabilities were higher compared to
the pre-test values, although all post-test probabilities for any defect
in PFJ are higher than the post-test probabilities for any defect in TFJ.
Discussion
Our study shows that the presence of crepitus in the knee and
history of patellar pain are signiﬁcantly associated with allTable III
Associations (OR (95%CI)) between clinical ﬁndings and PFJ MRI features in participants
Cartilage lesions in PFJ Osteoph
Pain at the patellar edges 0.88 (0.31e2.50) 1.31 (0.
Pain at the quadriceps tendon 2.41 (0.89e6.49) 0.66 (0.
Pain at the patellar ligament 2.02 (0.98e4.17) 1.14 (0.
Positive compression test 1.60 (1.10e2.31) 1.18 (0.
Present of crepitus 5.49 (3.79e7.94) 2.61 (2.
History of patellar pain 1.95 (1.39e2.72) 1.40 (1.
Current knee pain 1.54 (0.93e2.55) 0.90 (0.
Adjusted for age, BMI and TFJ MRI features; bold OR (95%CI) has a P < 0.001.
* The MRI deﬁnition for knee OA (PF and/or TF) is described in the Method section.prevalent MRI features of the PFJ in women aged 45e60 years
without knee OA. No signiﬁcant associations were found between
any clinical ﬁnding and prevalent TFJ MRI features. The post-test
probabilities of crepitus and history of patellar pain for any lesion
in PFJ were higher than the pre-test values and higher than the
post-test probabilities for any lesion in the TFJ. Testing positive on
both of these tests gives almost 72% certainty of having an osteo-
arthritic lesion in the PFJ.
To illustrate that these clinical ﬁndings are associated with knee
OA the analyses were also performed in all knees (with andwithout
OA). These results are shown in Supplementary data (S1) and show
similar or higher associations between the clinical ﬁndings and PFJ
MRI features or TFJ MRI features. In addition, the association be-
tween history of patellar pain and osteophytes in PFJ and in TFJ is
signiﬁcant. Furthermore, the subsequent analyses of the indepen-
dent association of each MRI feature with the clinical ﬁndings show
that crepitus is still associatedwith cartilage lesions in the PFJ when
additionally adjusted for the other PFJ MRI features (data shown in
Supplementary ﬁle [Table S1(d)]), but with a slightly lower esti-
mate, probably due to the correlations between the separate fea-
tures. This strengthens our conclusion that crepitus is an indicatorwithout any knee OA based on MRI*
ytes in PFJ Cysts in PFJ Bone marrow lesions in PFJ
58e2.98) 0.50 (0.11e2.20) 1.38 (0.58e3.31)
25e1.77) e 0.91 (0.26e3.18)
62e2.12) 0.79 (0.32e1.97) 0.98 (0.42e2.28)
86e1.61) 1.18 (0.80e1.75) 0.97 (0.67e1.40)
00e3.40) 2.82 (2.00e3.98) 3.70 (2.71e5.04)
07e1.85) 1.86 (1.32e2.61) 1.83 (1.33e2.50)
60e1.35) 1.58 (0.98e2.56) 2.09 (1.38e3.15)
Table IV
Associations (OR (95%CI)) between clinical ﬁndings and TFJ MRI features in participants without any knee OA based on MRI*
Cartilage lesions in TFJ Osteophytes in TFJ Cysts in TFJ BMLs in TFJ
Pain at the patellar edges 1.18 (0.37e3.81) 1.25 (0.57e2.75) e 0.43 (0.10e1.85)
Pain at the quadriceps tendon 0.86 (0.19e3.87) 3.19 (1.23e8.27) 2.64 (0.84e8.33) 0.67 (0.15e2.97)
Pain at the patellar ligament 1.67 (0.74e3.76) 1.29 (0.68e2.45) 0.83 (0.28e2.46) 0.79 (0.32e1.95)
Positive compression test 0.68 (0.42e1.09) 1.08 (0.80e1.46) 1.59 (1.07e2.36) 1.19 (0.82e1.73)
Present of crepitus 0.98 (0.67e1.44) 1.22 (0.91e1.61) 1.46 (0.99e2.17) 1.05 (0.75e1.46)
History of patellar pain 1.13 (0.77e1.66) 1.21 (0.91e1.62) 1.04 (0.70e1.55) 1.00 (0.71e1.41)
Current knee pain 0.95 (0.55e1.66) 1.02 (0.69e1.51) 0.88 (0.50e1.53) 0.78 (0.48e1.28)
Adjusted for age, BMI and PF MRI features; bold OR (95%CI) has a P < 0.001.
* The MRI deﬁnition for knee OA (PFOAMRI and/or TFOAMRI) is described in the Method section.
D. Schiphof et al. / Osteoarthritis and Cartilage 22 (2014) 631e638636of osteoarthritis (OA) lesions in the PFJ. Similar analysis for the
history of patellar pain showed the same trend.
To our knowledge this is the ﬁrst study that investigated the
association between clinical ﬁndings of the PFJ alone and PFJ MRI
features. Several previous studies examined the relationship be-
tween clinical ﬁndings (such as crepitus) and radiological OA in all
compartments of the knee20,21. Duncan et al. investigated how
radiographic severity and compartmental involvement inﬂuenced
symptoms in the knee, showing that radiographic PFJOA is associ-
ated with symptoms22. Crema et al. studied compartment speciﬁc
crepitus and showed that crepitus in the PFJ compartment associ-
ated with osteophytes in PFJ, but not with cartilage damage11. This
is in contrast to the results of the present study, but there are dif-
ferences between the two studies that may explain the discrep-
ancies in outcomes. The most important difference is the
symptomatic study population (inclusion criteria: knee pain) of
Crema et al.11 in contrast our study population, with only 14% knee
pain. Furthermore, in the present study crepitus was tested in
active ﬂexion and extension of the knee, whereas Crema et al.11
tested crepitus in passive ﬂexion and extension of the knee.
Another important difference is the cartilage lesion scoring, Crema
et al.11 used cartilage morphology based on a description of Disler
et al.23. Grade 1 in the grading of Disler et al.23 is described as
abnormal signal without a contour defect (which is the reasonwhy
Crema et al.11 used the grade2 as cut-off), whereas grade 1 in our
grading is described as a reduction of cartilage thickness (a contour
defect). Because of this difference in grading systems, we repeated
the analysis with grade 2 as cut-off for cartilage lesion and osteo-
phytes and found no differences for the association with crepitus;
similarly strong associations between crepitus and cartilage lesions,
and crepitus and osteophytes in the PFJ and no association for the
TFJ (data shown in Supplementary data S2). For history of patellar
pain the associations became stronger in the PFJ as well as in the
TFJ. Furthermore, we also analysed grade 1 vs no cartilage lesion (or
osteophyte) and even in this analysis we found signiﬁcant associ-
ations between crepitus and cartilage lesions, and crepitus and
osteophytes. This all strengthens our conclusion. Crema et al.11
found an association between medial meniscal damage and knee
crepitus; we did an additional analysis adjusting our results for
meniscal tears and/or meniscal degeneration. None of these fea-
tures changed the results (data not shown).
Crepitus of the knee is often described as a grinding noise with a
clearly palpable vibration, which could indicate cartilage damage inTable V
Pre- and post-test probability values of crepitus, history of patellar pain and the combin
Any defect in PFJ
Pre-test-PV (%) (n/N) Post-test-PV
Presence of crepitus 43.8 (651/1486) 64.3 (388/60
History of patellar pain 43.8 (661/1508) 54.7 (202/36
Combination 43.9 (661/1506) 71.8 (135/18
Pre-test-PV, pre-test predictive value; Post-test-PV, post-test predictive value; n, numbe
* The MRI deﬁnition for knee OA (TFOAMRI and/or PFOAMRI) is described in the Methothe PFJ. It is one of the signs for diagnosis of both TFJ and PFJOA
especially useful in primary care, as described in the EULAR
recommendation for diagnosis of knee OA10. In the present study of
a general population we showed that crepitus is a sign of lesions in
the PFJ rather than in the TFJ.
Several population-based studies20,21 found a similar frequency
of crepitus. In these symptomatic cohorts a signiﬁcant association
between crepitus and radiological OA (K&L  2) was found. Cibere
and colleagues20 showed, however, that crepitus was not associ-
ated with pre-radiological OA, which was based on contour defect
of cartilage thickness seen on MRI in combination with K&L  2 for
all knee compartments combined. In our study we analysed the PFJ
and TFJ separately. This enabled us to demonstrate the association
between crepitus and cartilage lesions for the PFJ alone. In knees
with OA (n¼ 242 knees) we found that crepitus still was associated
with PFJ MRI features and not with TFJ MRI features (data not
shown).
To our knowledge history of patellar pain has never been
investigated in relation to MRI features of OA. The association be-
tween history of patellar pain and all MRI features could indicate
that the changes in the knee seen on MRI (damage of the cartilage,
osteophyte, cysts, BMLs, or joint effusion) started at an earlier time-
point. Information about the cause and circumstances of the
patellar pain were unknown. Adjusting for knee injury in history
(“did you ever had a knee injury with a swollen knee or contacted a
medical doctor for a knee injury?” yes/no) did not change the re-
sults in signiﬁcance of MRI features (data not shown). History of
patellar pain could therefore also be an indicator of early PFOAMRI,
as already suggested in the review of Thomas et al.24.
A limitation of the present study is the lack of reproducibility of
the physical exam. In the literature the reported reproducibility of
physical examination of the knee is generally low or undeter-
mined25. Wood et al. (2006) reported for palpation for crepitus an
inter-observer agreement of 76.6% with a kappa of 0.5226.
Furthermore, we did not assess meniscal subluxation and bone
attrition. Little is known about meniscal subluxation in an early
stage of knee OA, and conﬂicting evidence is found for the associ-
ation between meniscal subluxation and pain27. Research showed
that meniscal subluxation is a risk factor for cartilage loss and joint
space narrowing in people with symptomatic knee OA28,29. Bone
attrition is traditionally seen with more progressive OA, although
with MRI bone attrition is also seen in pre-radiographic OA
stage30,31. In the present study these features are probablyation on any defect in PFJ or TFJ in participants without knee OA*
Any defect in TFJ
(%) (n/N) Pre-test-PV (%) (n/N) Post-test-PV (%) (n/N)
3) 43.1 (642/1488) 51.9 (314/605)
9) 43.2 (653/1510) 50.4 (186/369)
8) 43.2 (652/1508) 63.0 (119/189)
r of knees with presence of clinical ﬁndings; N, number of total knees in analysis.
d section.
D. Schiphof et al. / Osteoarthritis and Cartilage 22 (2014) 631e638 637underestimated which results in an underestimation of knee OA
detected by the MRI deﬁnition.
We used the PABAK for the inter-observer reliability of the semi-
quantitative scoring of the features of the MRI. The normal kappa is
affected by the distribution of data across the categories. In our
population the prevalence of the features is low, and distribution of
the data across the categories is uneven. Most knees were scored
0 and therefore distributed in the zero category of both deﬁnitions,
and there were features which had zero ﬁndings in certain cate-
gories. This is why the difference between the kappa and PABAK
sometimes is big, for example for deﬁnite osteophyte in the patella
(k ¼ 0.1 en PABAK ¼ 0.60).
In summary, the presence of crepitus is an important clinical
ﬁnding which is an indicator for osteoarthritic lesions in the PFJ
seen onMRI inwomenwithout knee OA, but not for the TFJ. History
of patellar pain is also an indicator of early osteoarthritic lesions of
PFJ seen on MRI in these women. Follow-up data need to conﬁrm
whether these tests have an additional diagnostic value on early
stage knee OA.
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